Biopsychosocial predictors of opioid use for pediatric postsurgical pain
阿片类药物用于小儿术后疼痛的生物心理社会预测因素
基本信息
- 批准号:10395431
- 负责人:
- 金额:$ 13.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:2-arachidonylglycerolAcute PainAddressAdenoidectomyAdolescenceAdultAnalgesicsAnxietyBeliefBiologicalBiological FactorsBloodCaringChildChildhoodClinicalCollaborationsCollectionComplexDataDehydrationDevelopmentEmergency department visitEmotionalEmotionsEndocannabinoidsFrequenciesGatekeepingGuidelinesHealth Care CostsHomeIatrogenesisInstructionInterdisciplinary StudyInterventionJointsLeadershipMeasuresMentored Patient-Oriented Research Career Development AwardModelingNauseaOnly ChildOperative Surgical ProceduresOpioidOpioid AnalgesicsOutcomePainPain intensityPain managementParent-Child RelationsParentsPatient EducationPatternPediatric Surgical ProceduresPharmaceutical PreparationsPostoperative PainPostoperative PeriodPractice ManagementPredispositionProceduresProcessProviderPsychological FactorsPsychosocial FactorQuality of lifeRecording of previous eventsResearchResearch PersonnelRiskSelf EfficacySeveritiesStandardizationStatistical ModelsSubgroupSurveysTelephoneTestingTimeTissuesTonsillectomyTrainingUncertaintyVentilatory DepressionYouthagedanandamidebiopsychosocialbiopsychosocial factorcareer developmentchronic painclinical developmentcopingdesigndiariesendogenous opioidsexperiencefollow up assessmentfollow-uphospital readmissionimprovedinnovationmedication administrationnegative affectnovelopioid disposalopioid misuseopioid policyopioid usepain outcomepain reliefparental influencepediatric patientspredictive modelingprescription opioidprogramsprospectivepsychologicpsychosocialrespiratoryresponsescreeningside effectskillssocial factorssocial influencetherapy developmentyoung adult
项目摘要
Abstract: Opioid analgesics are commonly used to manage children’s postoperative pain. Under-medication of
children’s postsurgical pain can have significant consequences including reduced quality of life, respiratory
issues, dehydration, and nausea, which can increase health care costs due to emergency department visits,
provider phone calls, and readmissions. In contrast, a proportion of parents may over-medicate children’s
postsurgical pain, potentially leading to greater respiratory depression and other opioid side effects. Given (a)
the potential repercussions of under- or over-medicating postsurgical pain in children, (b) uncertainty regarding
level of opioid analgesics needed for optimal postsurgical pain management, and (c) increasing societal focus
on the negative consequences of opioid medications, further understanding the patterns and predictors of
home opioid use and pain management following surgical procedures in children is necessary to guide
development of interventions to enhance appropriate analgesic use for pediatric postsurgical pain. The
proposed project is designed to address this gap in understanding by prospectively examining parent and child
predictors of the extent of opioid analgesic use following tonsillectomy and adenoidectomy (T&A) procedures in
pediatric patients aged 7 to 12 years. Parents and youth will complete preoperative measures regarding opioid
medication beliefs, pain-related beliefs and emotional responses, and history of painful experiences and opioid
use. At the time of IV placement for surgery, blood will be collected to assess children’s circulating
endocannabinoid levels. Following surgery, parents and youth will complete electronic diaries regarding pain,
emotions, medication use, and side-effects 3 times a day for 7 days and a 3-month follow-up survey assessing
additional opioid use and opioid disposal. The central aims of this proposal are to understand parent and child
factors that may predict opioid analgesic use following T&A procedures in order to inform predictive models for
opioid-related outcomes following pediatric surgeries more broadly. A key innovation of this project is the
examination of joint influences of parent and child factors on postoperative opioid use patterns. We
hypothesize that parents and children who tend to catastrophize more about painful experiences, have positive
beliefs regarding opioid efficacy, and less negative beliefs regarding opioid side effects will be more likely to
use opioid medications and be less likely to dispose of opioid medications. Identifying these parent and child
predictors could allow for the development of targeted screening and patient education in order to identify
potentially modifiable targets for interventions to improve pediatric postsurgical pain management and reduce
opioid-related risks. Further, this project provides critical career development support for a young investigator
focused on developing expertise in pediatric acute pain, opioid guidelines and clinical opioid use patterns,
advanced statistical modeling skill, leadership skills, and biological mechanisms related to pain and opioid use
which will inform an overall program of research focused on improving pain management practices for children.
摘要:阿片类镇痛药通常用于管理儿童术后疼痛。不足
儿童的术后疼痛可能会带来重大后果,包括生活质量,呼吸道
问题,脱水和恶心,可以增加由于急诊室就诊而增加医疗保健费用,
提供者电话和再入院。相比之下,一定比例的父母可能过度服从孩子的
术后疼痛,可能导致更大的呼吸道抑郁和其他阿片类药物副作用。给定(a)
儿童术后疼痛或过度服药的潜在影响,(b)有关的不确定性
最佳术后疼痛管理所需的阿片类镇痛药水平,以及(c)增加社会重点
关于阿片类药物的负面后果,进一步了解
在儿童外科手术程序之后,家庭使用阿片类药物的使用和疼痛管理是必要的
开发干预措施以增强儿科术后疼痛的适当镇痛作用。
拟议的项目旨在通过前瞻性检查父母和子女来解决这一差距
预测扁桃体切除术和腺样切除术(T&A)程序后使用oid镇痛的程度
儿科患者7至12岁。父母和青年将完成有关阿片类药物的术前措施
药物信念,与疼痛有关的信念和情感反应以及痛苦的经历和阿片类药物的历史
使用。在静脉注射手术时,将收集血液以评估儿童循环
内源性大麻素水平。手术后,父母和青年将完成有关疼痛的电子日记,
情绪,用药和副作用每天3次,持续7天,并进行3个月的随访评估
其他阿片类药物使用和阿片类药物处置。该提议的主要目的是了解父母和孩子
可能预测按照T&A程序进行阿片类镇痛药的因素,以便为预测模型提供信息
小儿手术后,阿片类药物相关的结果更广泛。该项目的关键创新是
检查父母和儿童因素对术后阿片类药物使用模式的关节影响。我们
假设倾向于灾难性的父母和孩子更多地涉及痛苦的经历,具有积极的态度
关于阿片类药物有效性以及对阿片类药物副作用的负面信念的信念更可能更有可能
使用阿片类药物,不太可能处置阿片类药物。确定这些父母和孩子
预测因素可以允许开发目标筛查和患者教育,以确定
潜在的可修改目标,以改善儿科术后疼痛管理并减少
阿片类药物相关的风险。此外,该项目为年轻调查员提供了关键的职业发展支持
专注于发展小儿急性疼痛,阿片类药物指南和临床阿片类药物使用模式的专业知识,
先进的统计建模技能,领导技能和与疼痛和阿片类药物使用有关的生物学机制
这将为一项整体研究计划提供信息,重点是改善儿童疼痛管理实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amanda Leigh Stone其他文献
Amanda Leigh Stone的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amanda Leigh Stone', 18)}}的其他基金
Biopsychosocial predictors of opioid use for pediatric postsurgical pain
阿片类药物用于小儿术后疼痛的生物心理社会预测因素
- 批准号:
10614954 - 财政年份:2021
- 资助金额:
$ 13.36万 - 项目类别:
相似国自然基金
电针调控Nrf2表达抑制巨噬细胞铁死亡进程缓解急性痛风性关节炎疼痛的机制研究
- 批准号:82305369
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
急性牙髓炎疼痛昼夜变化的中枢调控新机制:节律基因Per1/HIF-1α轴调控铁代谢介导小胶质细胞差异性极化
- 批准号:82370986
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
围术期睡眠剥夺激活外周感觉神经元芳香烃受体致术后急性疼痛慢性化
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
前扣带回沉默突触激活介导急性疼痛慢性化的环路和细胞机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
前扣带回沉默突触激活介导急性疼痛慢性化的环路和细胞机制
- 批准号:82271263
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids
重复使用 THC 和 CBD 含量不同的大麻:对滥用倾向、实验性疼痛和血浆内源性大麻素的影响
- 批准号:
10366284 - 财政年份:2022
- 资助金额:
$ 13.36万 - 项目类别:
Repeated Administration of Cannabis Varying in THC and CBD: Effects on Abuse Liability, Experimental Pain and Plasma Endocannabinoids
重复使用 THC 和 CBD 含量不同的大麻:对滥用倾向、实验性疼痛和血浆内源性大麻素的影响
- 批准号:
10682383 - 财政年份:2022
- 资助金额:
$ 13.36万 - 项目类别:
Endocannabinoid Targeting for Opioid Induced Respiratory Depression
内源性大麻素靶向治疗阿片类药物引起的呼吸抑制
- 批准号:
10508272 - 财政年份:2022
- 资助金额:
$ 13.36万 - 项目类别:
Endocannabinoid system and HIV-related neuropathic pain
内源性大麻素系统和 HIV 相关的神经性疼痛
- 批准号:
10242327 - 财政年份:2021
- 资助金额:
$ 13.36万 - 项目类别:
Biopsychosocial predictors of opioid use for pediatric postsurgical pain
阿片类药物用于小儿术后疼痛的生物心理社会预测因素
- 批准号:
10614954 - 财政年份:2021
- 资助金额:
$ 13.36万 - 项目类别: